Loading...

TransMedics Group, Inc.

TMDXNASDAQ
Healthcare
Medical - Devices
$108.12
$1.33(1.25%)

TransMedics Group, Inc. (TMDX) Company Profile & Overview

Explore TransMedics Group, Inc.’s business operations, leadership, sector classification, and key company facts including IPO date, industry, and contact details.

TransMedics Group, Inc. (TMDX) Company Profile & Overview

TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and customized technology to replicate near-physiologic conditions for donor organs outside of the human body. Its Organ Care System includes OCS LUNG for the preservation of standard criteria donor lungs for double-lung transplantation; OCS Heart, a technology for extracorporeal perfusion and preservation of donor hearts; and OCS Liver for the preservation of donor livers. The company was founded in 1998 and is headquartered in Andover, Massachusetts.

SectorHealthcare
IndustryMedical - Devices
CEOWaleed H. Hassanein

Contact Information

978 552 0900
200 Minuteman Road, Andover, MA, 01810

Company Facts

728 Employees
IPO DateMay 2, 2019
CountryUS
Actively Trading

Frequently Asked Questions

;